Cabaletta Bio Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -5.4% | +17.0% | +8.4% | -0.5% | +10.4% | +3.6% | -3.5% | -26.3% | -476.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -126.0% | – | – | |
| – | +26.2% | +26.1% | +6.7% | +12.2% | -2.9% | +13.7% | +29.7% | +5.8% | -9.1% | +3.2% | +18.9% | – | |
| – | +17.6% | +5.9% | +12.8% | -1.4% | +22.2% | -1.6% | +1.8% | -18.2% | -5.1% | +8.2% | +9.3% | – | |
| – | +24.0% | +21.1% | +8.0% | +9.1% | +2.2% | +9.9% | +23.6% | +1.5% | -8.5% | +4.0% | +17.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | – | -60.7% | +94.2% | +2.3% | -5.0% | +14.6% | -18.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -76.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.